Clorox CO /DE/ Form 4 insider transactions

Nina Barton, EVP-Chief Growth & Strategy Of of Clorox Co /De/, reported a transaction in 1,681 shares of common stock on July 22, 2026.

Chris T Hyder, EVP-Chief Operating Officer of Clorox Co /De/, reported a transaction in 277 shares of common stock on July 15, 2026.

Stephanie Plaines, a Director at The Clorox Company, acquired deferred stock units through dividend reinvestment and in lieu of director's fees, as reported in a Form 4 filing.

Clorox Director Pierre R. Breber reported transactions involving deferred stock units acquired through dividend reinvestment and in lieu of director's fees.

Matthew J. Shattock, a Director at The Clorox Company, reported transactions involving deferred stock units acquired through dividend reinvestment and in lieu of director's fees.

Clorox Director Pierre R. Breber reported a transaction involving the sale of 5,000 shares of common stock.

Clorox CFO Luc Bellet reported a transaction involving the withholding of shares to cover tax obligations upon vesting of restricted stock.

Director Christopher J. Williams acquired 265.3672 deferred stock units in lieu of quarterly director fees.

Director Russell Weiner acquired 498.0409 deferred stock units in The Clorox Company through dividend reinvestment and director fee compensation.

Clorox Director Pierre Breber acquired 325.6779 deferred stock units in lieu of quarterly director fees.

Director Matthew J. Shattock acquired 506.61 deferred stock units in lieu of quarterly director fees, increasing his total holdings.

Clorox EVP Chris T Hyder reported a routine disposition of 41 shares for tax obligations and an acquisition of 10 shares via dividend reinvestment.

Clorox EVP Stacey Grier reported the withholding of 32 common shares to cover tax obligations related to restricted stock vesting, maintaining a beneficial ownership of 32,116 shares.

Clorox Director Christopher J. Williams increased his beneficial ownership of the company's stock through the acquisition of Deferred Stock Units via dividend reinvestment, annual awards, and director fee conversions.

Clorox Director Russell J. Weiner increased his beneficial ownership of the company's deferred stock units through dividend reinvestment, annual awards, and director fee conversions.

Clorox Director Matthew J. Shattock increased his beneficial ownership of the company's stock through the acquisition of deferred stock units via dividend reinvestment, annual award, and director's fees, signaling continued confidence in the company.

Clorox Co. Director Stephanie Plaines increased her beneficial ownership of the company's stock through the acquisition of Deferred Stock Units.

A.D. David MacKay, a Director at Clorox, increased his beneficial ownership of the company's stock through deferred stock unit acquisitions and an annual award.

Clorox Company Director Esther Lee increased her beneficial ownership through multiple acquisitions of Deferred Stock Units, including dividend reinvestments and an annual award.

Clorox Director Spencer C. Fleischer increased his beneficial ownership of the company's stock through the acquisition of Deferred Stock Units via dividend reinvestment, annual awards, and director's fees.

Clorox Director Julia Charter increased her beneficial ownership of the company's common stock equivalents through several deferred stock unit acquisitions in 2025.

Clorox Director Pierre R. Breber acquired additional deferred stock units through dividend reinvestment, annual awards, and in lieu of director fees, increasing his beneficial ownership.

Clorox Director Stephen B. Bratspies received an annual award of 1,637.8577 Deferred Stock Units, to be settled in company stock upon his departure.

Clorox Director Gina Boswell was granted 825.0862 Deferred Stock Units as an annual award, settling in common stock upon her departure.

Clorox's Chief Operating Officer, Eric H. Reynolds, disposed of 255 shares of common stock to cover tax obligations related to restricted stock units.

Clorox CEO Linda J Rendle reported a disposition of 829 common shares to cover tax obligations related to previously granted restricted stock units.

Clorox VP and Corporate Controller Laurene E. Peck disposed of 24 shares of common stock to cover tax obligations related to restricted stock units.

Kirsten Marriner, EVP Chief Admin Officer at Clorox, disposed of 310 shares of common stock to cover tax obligations related to restricted stock units.

Clorox EVP Chris T Hyder disposed of 133 common shares to cover tax obligations related to restricted stock units.

Clorox EVP Stacey Grier disposed of 65 shares of common stock to cover tax obligations related to restricted stock units.